Morphic Medical Announces CE Mark for RESET® Endoscopic Device Therapy

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Morphic-Medical

More Like This

PR Newswire associated0

Morphic Medical Announces CEO Transition

PR Newswire associated0

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network

UEG Week: Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes

BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

PR Newswire associated0

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

RefluxStop® takes center stage at 2025 European Foregut Society meeting